Cue Biopharma logo

Cue Biopharma

CUE | NASDAQ
Chart Builder DCF Calculator
$14.10
-$2.02 (-12.53%)
At close: Nov 16, 2026, 4:00 PM ET
$13.80
-$0.30 (-2.13%)
After-hours: Nov 16, 2026, 7:30 PM ET
-12.53%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
52
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #238/1021 (Top 23%)

Key Statistics

Market Data

Market Cap $102.43M
1D Range
13.56 15.81
52W Range
5.31 37.84

Valuation (TTM)

PE -0.52
PB 44.34
EV/EBITDA -0.98

Valuation (NTM)

Forward PE N/A
Forward PEG -0.01
Price Target $83.00
Loading financial charts...

Profile

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical enterprise focused on creating biological therapies. Its central objective is the precise manipulation of the human immune system to address a...

Sector Healthcare
Industry Biotechnology
Employees 29
IPO Date Jan 2, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Nov 18, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.